Statistics
Publications
2
Citations
27
H-Index
2
Active since
2023
Heng‐Chung Kung is an author at Johns Hopkins Medicine specializing in t cell activation, t cell biology, and cancer immunology.
Publications per year
2023–2024
2
2
Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC
Jianxin Wang, Tengyi Zhang, Pan Li et al. · Cancer Letters · 2023 · 13 citations
Life Sciences, Immunology, Oncology +14
1–2 of 2